Pharma exports to US seen muted this year

Indian pharma exports to the US face a subdued outlook this year. Policy uncertainties, falling generic prices, and regional conflicts are impacting shipments. US buyers are managing inventories more closely. A push for local manufacturing in the US also poses a challenge. This situation is creating caution among buyers for large forward orders.